support thyroid research
Clinical Thyroidology for Patients

Clinical Thyroidology for Patients, edited by Dr. Alan Farwell, is a collection of summaries of recently published articles from the medical literature that covers the broad spectrum of thyroid disorders.

Starting with the May 2009 issue, Clinical Thyroidology for Patients will be published on a monthly basis and include summaries of research studies that were discussed in the previous month’s issue of Clinical Thyroidology, a publication of the American Thyroid Association for physicians. Dr. Hershman is the Editor-in-Chief of Clinical Thyroidology.

Like us on Facebook

Clinical Thyroidology
for Patients Volume 6

Volume 6 Issue 8

Now available in pdf format for saving and printing and Web page format for viewing online

PDF Format for Saving and Printing

Clinical Thyroidology for Patients Volume 6 Issue 8 (PDF file, 1.26 MB)


Editor’s Comments

HYPOTHYROIDISM Desiccated thyroid extract vs Levothyroxine in the treatment of hypothyroidism
Hoang TD et al Desiccated thyroid extract compared with levothyroxine in the treatment of hypothyroidism: A randomized, double-blind, crossover study. J Clin Endo- crinol Metab 2013;98:1982-90. Epub March 28, 2013.
PDF File for saving and printing
, 72 KB)

THYROID AND PREGNANCY IVF pregnancy outcomes in women with treated hypothyroidism and women without thyroid disease
Busnelli A et al. In vitro fertilization outcomes in treated hypothyroidism. Thyroid. April 2, 2013 [Epub ahead of print].
PDF File for saving and printing, 84 KB)

HYPERTHYROIDISM Severe sight-threatening orbitopathy is a very rare event in the natural history of Graves’ disease
Tanda ML et al Prevalence and natural history of Graves’ orbitopathy in a large series of patients with newly diagnosed Graves’ hyperthyroidism seen at a single center. J Clin Endocrinol Metab 2013;98:1443-9.
PDF File for saving and printing, 79 KB)

THYROID CANCER Stimulated thyroglobulin levels obtained after thyroidectomy are a good indicator for risk of future recurrence from thyroid cancer.
Piccardo, A. et al. Focus on high-risk DTC patients: high postoperative serum thyroglobulin level is a strong predictor of disease persistence and is associated to progression-free survival and overall survival. Clin Nucl Med 38 (1): 18-24, 2013.
PDF File for saving and printing, 77 KB)

THYROID CANCER Only a few thyroid cancer patients have a cancer recurrence within 8 years of initial therapy
Durante C et al, Papillary thyroid cancer: time course of recurrences during postsurgery surveillance. J Clin Endocrinol Metab 2013;98:636-42. Epub January 4, 2013.
PDF File for saving and printing, 77 KB)